FDA行业指南:有关仿制药研发的书面咨询 2020

2020-12-22 美国食品和药品监督管理局 FDA

FDA行业指南:有关仿制药研发的书面咨询 2020

中文标题:

FDA行业指南:有关仿制药研发的书面咨询 2020

发布日期:

2020-12-22

简要介绍:

FDA行业指南:有关仿制药研发的书面咨询 2020

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=28bcd1c002066066, title=FDA行业指南:有关仿制药研发的书面咨询 2020, enTitle=, guiderFrom=FDA, authorId=0, author=, summary=FDA行业指南:有关仿制药研发的书面咨询 2020, cover=, journalId=0, articlesId=null, associationId=486, associationName=美国食品和药品监督管理局, associationIntro=美国食品和药品监督管理局是美国公共卫生及服务部的一个代理商,其由委员会办公室和4个监督核心功能理事机构组成。, copyright=0, guiderPublishedTime=Tue Dec 22 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>FDA行业指南:有关仿制药研发的书面咨询 2020</p>, tagList=[TagDto(tagId=6388, tagName=仿制药)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=40, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2043, appHits=9, showAppHits=0, pcHits=332, showPcHits=2034, likes=0, shares=0, comments=0, approvalStatus=1, publishedTime=Sat Mar 06 16:33:27 CST 2021, publishedTimeString=2020-12-22, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sat Mar 06 16:29:51 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 20:49:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击:
评论区 (0)
#插入话题